1. < Publications

Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities

By sjmartinez • February 14, 2025

Pandey A, Alcaraz M Jr, Saggese P, Soto A, Gomez E, Jaldu S, Yanagawa J, Scafoglio C. Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities. Cancers (Basel). 2025 Jan 30;17(3):466. doi: 10.3390/cancers17030466. PMID: 39941833.

Tags: Cancer, glucose, Metabolism, Publications, Pulmonary, Critical Care & Sleep Medicine, SGLT2 inhibitor

Related Posts

Methylation risk score of C-reactive protein associates sleep health with related health outcomes

Wang Z, Wallace DA, Spitzer BW, Huang T, Taylor KD, Rotter JI, Rich SS, Liu PY, Daviglus ML, Hou L, Ramos AR, Kaur S, Durda[...]

Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma

Finn RS, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Cheng AL, Galle PR, Kaneko[...]

Structural mechanisms of PIP2 activation and SEA0400 inhibition in human cardiac sodium-calcium exchanger NCX1

Xue J, Zeng W, John S, Attiq N, Ottolia M, Jiang Y. Structural mechanisms of PIP2activation and SEA0400 inhibition in human cardiac sodium-calcium exchanger NCX1.[...]